Suchergebnisse - "Vergnenègre, Alain"

PubPharm (158)

1

Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: The New England journal of medicine | 2023

von Tsuboi, M. | Herbst, R. | John, T. | +118

CommentIn: Nat Rev Clin Oncol. 2023 Aug;20(8):504. - PMID 37311902

2

Safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination in stage IV non-small-cell lung cancer : An open-label phase II trial (VinMetAtezo)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Vergnenegre, A. | Monnet, I. | Ricordel, C. | +13

3

Author Correction : BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

enthalten in: Scientific reports | 2023

von Karachaliou, N. | Codony-Servat, J. | Teixidó, C. | +31

ErratumFor: Sci Rep. 2015 Dec 07;5:17499. - PMID 26639561

4

Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure : Real-world data from a French hospital

enthalten in: Frontiers in oncology | 2023

von Pinet, S. | Durand, S. | Perani, A. | +20

5

First-Line Nivolumab Plus Ipilimumab in Advanced NSCLC : 4-Year Outcomes From the Randomized, Open-Label, Phase 3 CheckMate 227 Part 1 Trial

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Paz-Ares, L. | Ramalingam, S. | Ciuleanu, T. | +36

CommentIn: J Thorac Oncol. 2022 Feb;17(2):176-178. - PMID 35074222

6

Multicenter phase II trial of nintedanib plus docetaxel in second-line treatment in advanced non-squamous non-small cell lung cancer patients refractory to first-line platin-based chemotherapy (REFRACT GFPC 02-15 study)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Auliac, J. | Monnet, I. | Bizieux, A. | +10

7

Updated Overall Survival Analysis From IMpower110 : Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1-Selected NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2021

von Jassem, J. | de Marinis, F. | Giaccone, G. | +16

8

Economic analyses of immune-checkpoint inhibitors to treat lung cancer

enthalten in: Expert review of pharmacoeconomics & outcomes research | 2021

von Vergnenegre, A. | Chouaid, C.

9

Phase III randomized study of carboplatin pemetrexed with or without bevacizumab with initial versus "at progression" cerebral radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis

enthalten in: Therapeutic advances in medical oncology | 2021

von Monnet, I. | Vergnenègre, A. | Robinet, G. | +17

10

Two-Stage Bronchoscopic Endobronchial Valve Treatment Can Lead to Progressive Lung Volume Reduction and May Decrease Pneumothorax Risk

enthalten in: International journal of chronic obstructive pulmonary disease | 2021

von Egenod, T. | Tricard, J. | Fumat, R. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]